You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

premixed insulin therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes Trial in Changsha (metformin+empagliflozin+insulin glargine, IDegLira, premixed insulin analogues)

Recruiting
  • Type 2 Diabetes Mellitus
  • metformin+empagliflozin+insulin glargine
  • +2 more
  • Changsha, Hunan, China
    Xiangya Hospital of Central South University
Sep 15, 2022

Regimen Switch After Intensive Insulin Therapy

Recruiting
  • Insulin
  • Continuous intensive insulin therapy
  • Shanghai, Shanghai, China
  • +1 more
Oct 27, 2021

Type 2 Diabetes Treated With Insulin Trial (premixed insulin therapy, basal bolus insulin therapy)

Completed
  • Type 2 Diabetes Treated With Insulin
  • premixed insulin therapy
  • basal bolus insulin therapy
  • (no location specified)
Feb 1, 2021

Type 2 Diabetes Trial in China (INSULIN GLARGINE (HOE901), Insulin Glulisine, Biphasic insulin aspart 30)

Completed
  • Type 2 Diabetes Mellitus
  • INSULIN GLARGINE (HOE901)
  • +5 more
  • China, China
    CHINA
Apr 21, 2022

Diabetes, Type 1, Type 1 Diabetes Trial in Dhaka, Mwanza (Insulin Glargine, NPH or premixed 70/30 (human insulin))

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • Type 1 Diabetes
  • Insulin Glargine
  • NPH or premixed 70/30 (human insulin)
  • Dhaka, Bangladesh
  • +2 more
Nov 30, 2022

Type 2 Diabetes Trial in Nanjing (Professional flash glucose mornitoring, Personal flash glucose mornitoring)

Completed
  • Type 2 Diabetes
  • Professional flash glucose mornitoring
  • Personal flash glucose mornitoring
  • Nanjing, Jiangsu, China
    Nanjing First Hospital
Sep 22, 2021

Stratification of Type 2 Diabetes Microvascular Complications

Recruiting
  • Type 2 Diabetes
  • +4 more
  • Diabetes Microvascular Complication Tests
  • Singapore, Singapore
    Singapore General Hospital
Mar 14, 2023

Insulin Pump,Continuous Glucose Monitoring Technology Trial in Guandong (Insulin Glargine, Metformin, Dapagliflozin)

Recruiting
  • Insulin Pump，Continuous Glucose Monitoring Technology
  • Insulin Glargine
  • +3 more
  • Guandong, China
    刘烈华
Nov 7, 2023

Liver Dysfunction, Liver Metastasis Colon Cancer, Liver Regeneration Trial (High-Dose Insulin Therapy)

Not yet recruiting
  • Liver Dysfunction
  • +2 more
  • High-Dose Insulin Therapy
  • (no location specified)
Nov 6, 2023

s and Activity Data in Type 2 Diabetes on Different Treatments

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Lifestyle
  • +4 more
  • (no location specified)
Sep 16, 2022

Type 2 Diabetic Patients: Real-life Study on Effectiveness and

Not yet recruiting
  • Diabete Type 2
    • (no location specified)
    Nov 2, 2023

    Time in Range, Artificial Intelligence, Insulin Therapy Trial in Jingan (Wechat program)

    Recruiting
    • Time in Range
    • +2 more
    • Wechat program
    • Shanghai, Shanghai, China
      Xiaolong Zhao
    Oct 21, 2022

    Type 2 Diabetes Trial in Graz (Insulin Aspart, Insulin Aspart 30, Insulin Aspart 70)

    Completed
    Has Results
    • Type 2 Diabetes
    • Insulin Aspart
    • +2 more
    • Graz, Austria
      Medical University of Graz, Department for Internal Medicine
    Jun 9, 2021

    Type 1 Diabetes Trial in Vancouver (Frexalimab, Placebo, Insulin)

    Recruiting
    • Type 1 Diabetes Mellitus
    • Vancouver, British Columbia, Canada
      Investigational Site Number : 1240001
    Oct 31, 2023

    Prostate Cancer, Insulin Resistance, Diabetes, Type 2 Trial in Buffalo (Pioglitazone 30 mg, Placebo)

    Recruiting
    • Prostate Cancer
    • +3 more
    • Pioglitazone 30 mg
    • Placebo
    • Buffalo, New York
      Diabetes and Endocrinology Research Center of WNY
    Oct 26, 2022

    Type 2 Diabetes Treated With Insulin Trial (t:slim X2 insulin pump with Control-IQ technology 1.5 and Dexcom G6 CGM, Standard

    Not yet recruiting
    • Type 2 Diabetes Treated With Insulin
    • t:slim X2 insulin pump with Control-IQ technology 1.5 and Dexcom G6 CGM
    • Standard Therapy plus continuous glucose monitoring (CGM)
    • (no location specified)
    Mar 14, 2023

    Diabetes, Type 1, Diabetes, Type 2 Trial in Erzurum (Health Belief Model-Based Mobile Online Training)

    Completed
    • Diabetes Mellitus, Type 1
    • Diabetes Mellitus, Type 2
    • Health Belief Model-Based Mobile Online Training
    • Erzurum, Turkey
      Atatürk Universty
    Mar 24, 2023

    Perioperative Hyperglycaemia, Insulin Therapy, Elective Surgery Trial in Basel, Bern (CamAPS HX, Standard insulin therapy)

    Recruiting
    • Perioperative Hyperglycaemia
    • +9 more
    • CamAPS HX
    • Standard insulin therapy
    • Basel, Switzerland
    • +1 more
    Dec 6, 2022

    Diabetes, Type 2, Insulin Resistance, Diabetes Trial in Cairo (High intensity interval training, moderate intensity aerobic

    Recruiting
    • Diabetes Mellitus, Type 2
    • Insulin Resistance, Diabetes
    • High intensity interval training
    • moderate intensity aerobic exercise
    • Cairo, Egypt
    • +3 more
    Jun 3, 2023

    Type 2 Diabetes, Multiple Dose Insulin Therapy Trial (Personalized treatment)

    Not yet recruiting
    • Type 2 Diabetes Mellitus
    • Multiple Dose Insulin Therapy
    • Personalized treatment
    • (no location specified)
    Nov 18, 2023

    Cystic Fibrosis Trial in Minneapolis, Saint Paul (novolog insulin, levemir insulin, )

    Completed
    • Cystic Fibrosis
    • novolog insulin
    • +2 more
    • Minneapolis, Minnesota
    • +1 more
    Aug 8, 2022

    Liver Cirrhosis, Diabetes Trial in Shanghai (Insulin Degludec and Insulin Aspart)

    Recruiting
    • Liver Cirrhosis
    • Diabetes
    • Insulin Degludec and Insulin Aspart
    • Shanghai, Shanghai, China
      Xiaolong Zhao
    Nov 29, 2022

    Automated Insulin Titration Algorithm Compared to Standard

    Completed
    • Diabetes
      • Montpellier, France
        Uhmontpellier
      Oct 21, 2022

      Type 2 Diabetes Trial in Nanjing (Add oral hyppoglycemia drug, Add GLP-1 receptor agonist, Change insulin)

      Recruiting
      • Type 2 Diabetes Mellitus
      • Add oral hyppoglycemia drug
      • +2 more
      • Nanjing, China
        Nanjing First Hospital, Nanjing Medical Univesity
      Oct 11, 2022

      Type 1 Diabetes Trial in Nantes (Bio-mathematical model, Without bio-mathematical model)

      Completed
      • Type 1 Diabetes
      • Bio-mathematical model
      • Without bio-mathematical model
      • Nantes, France
        CHU de Nantes
      Oct 20, 2022